Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Toner is not a single, well-defined pharmaceutical drug but is often used commercially as a term for topical skincare products, usually solutions applied to the skin. Multiple products marketed as "toner" may contain different active ingredients and serve different purposes, such as acne treatment or skin hydration. For example, KAVI Toner is a topical product containing 0.2% salicylic acid and 3% cucumber extract, formulated for the final-stage cleansing of skin, providing exfoliation, reduction of pore size, and antioxidant benefits. Another product, Toner PG, is a combination of pregabalin and methylcobalamin used orally for neuropathic pain, but this is not a topical toner and is a pharmaceutical combination, not a cosmetic or OTC topical product. When specifically referring to "toner" in the context of active dermatological ingredients, the most relevant drug-related form is a topical solution containing salicylic acid, used for skin conditions like acne, rosacea, eczema, and psoriasis[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on toner.